Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00AHD
|
|||
| Former ID |
DNC007781
|
|||
| Drug Name |
Anthracen-10-yl(10H-phenothiazin-10-yl)methanone
|
|||
| Synonyms |
CHEMBL392577; anthracen-10-yl(10H-phenothiazin-10-yl)methanone; BDBM50219206; 10-(9-Anthrylcarbonyl)Phenothiazine; Anthracen-9-yl (10H-phenothiazine-10yl) methanone, 5
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H17NOS
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C(=O)N4C5=CC=CC=C5SC6=CC=CC=C64
|
|||
| InChI |
1S/C27H17NOS/c29-27(26-20-11-3-1-9-18(20)17-19-10-2-4-12-21(19)26)28-22-13-5-7-15-24(22)30-25-16-8-6-14-23(25)28/h1-17H
|
|||
| InChIKey |
GEDDVJWUHICGPI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| WikiPathways | Irinotecan Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.